| Literature DB >> 34217893 |
Rhiannon B Werder1, Joseph E Kaserman2, Michael S Packer3, Jonathan Lindstrom-Vautrin4, Carlos Villacorta-Martin4, Lauren E Young3, Yvonne Aratyn-Schaus3, Francine Gregoire3, Andrew A Wilson5.
Abstract
Alpha-1 antitrypsin deficiency (AATD) is most commonly caused by the Z mutation, a single-base substitution that leads to AAT protein misfolding and associated liver and lung disease. In this study, we apply adenine base editors to correct the Z mutation in patient induced pluripotent stem cells (iPSCs) and iPSC-derived hepatocytes (iHeps). We demonstrate that correction of the Z mutation in patient iPSCs reduces aberrant AAT accumulation and increases its secretion. Adenine base editing (ABE) of differentiated iHeps decreases ER stress in edited cells, as demonstrated by single-cell RNA sequencing. We find ABE to be highly efficient in iPSCs and do not identify off-target genomic mutations by whole-genome sequencing. These results reveal the feasibility and utility of base editing to correct the Z mutation in AATD patient cells.Entities:
Keywords: adenine base editor; alpha-1 antitrypsin deficiency; base edit; hepatocyte; human induced pluripotent stem cells; iHep; iPSC; single cell RNA sequencing; whole genome sequencing
Mesh:
Substances:
Year: 2021 PMID: 34217893 PMCID: PMC8571173 DOI: 10.1016/j.ymthe.2021.06.021
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 12.910